The frailty index outperforms DNA methylation age and its derivatives as an indicator of biological age
Tóm tắt
The measurement of biological age as opposed to chronological age is important to allow the study of factors that are responsible for the heterogeneity in the decline in health and function ability among individuals during aging. Various measures of biological aging have been proposed. Frailty indices based on health deficits in diverse body systems have been well studied, and we have documented the use of a frailty index (FI34) composed of 34 health items, for measuring biological age. A different approach is based on leukocyte DNA methylation. It has been termed DNA methylation age, and derivatives of this metric called age acceleration difference and age acceleration residual have also been employed. Any useful measure of biological age must predict survival better than chronological age does. Meta-analyses indicate that age acceleration difference and age acceleration residual are significant predictors of mortality, qualifying them as indicators of biological age. In this article, we compared the measures based on DNA methylation with FI34. Using a well-studied cohort, we assessed the efficiency of these measures side by side in predicting mortality. In the presence of chronological age as a covariate, FI34 was a significant predictor of mortality, whereas none of the DNA methylation age-based metrics were. The outperformance of FI34 over DNA methylation age measures was apparent when FI34 and each of the DNA methylation age measures were used together as explanatory variables, along with chronological age: FI34 remained significant but the DNA methylation measures did not. These results indicate that FI34 is a robust predictor of biological age, while these DNA methylation measures are largely a statistical reflection of the passage of chronological time.
Tài liệu tham khảo
Accomando WP, Wiencke JK, Houseman EA, Nelson HH, Kelsey KT (2014) Quantitative reconstruction of leukocyte subsets using DNA methylation. Genome Biol 15:R50. doi:10.1186/gb-2014-15-3-r50
Assenov Y, Muller F, Lutsik P, Walter J, Lengauer T, Bock C (2014) Comprehensive analysis of DNA methylation data with RnBeads. Nat Methods 11:1138–1140. doi:10.1038/nmeth.3115
Bocklandt S, Lin W, Sehl ME, Sanchez FJ, Sinsheimer JS, Horvath S, Vilain E (2011) Epigenetic predictor of age. PLoS One 6:e14821. doi:10.1371/journal.pone.0014821
Breitling LP, Saum KU, Perna L, Schottker B, Holleczek B, Brenner H (2016) Frailty is associated with the epigenetic clock but not with telomere length in a German cohort. Clin Epigenetics 8:21. doi:10.1186/s13148-016-0186-5
Chen BH et al (2016) DNA methylation-based measures of biological age: meta-analysis predicting time to death. Aging 8:1844–1865. doi:10.18632/aging.101020
Christiansen L, Lenart A, Tan Q, Vaupel JW, Aviv A, McGue M, Christensen K (2016) DNA methylation age is associated with mortality in a longitudinal Danish twin study. Aging Cell 15:149–154. doi:10.1111/acel.12421
Fraga MF et al (2005) Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A 102:10604–10609. doi:10.1073/pnas.0500398102
Fried LP et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:M146–M156
Hannum G et al (2013) Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol Cell 49:359–367. doi:10.1016/j.molcel.2012.10.016
Horvath S (2013) DNA methylation age of human tissues and cell types. Genome Biol 14:R115. doi:10.1186/gb-2013-14-10-r115
Horvath S et al (2015) Decreased epigenetic age of PBMCs from Italian semi-supercentenarians and their offspring. Aging 7:1159–1170. doi:10.18632/aging.100861
Houseman EA et al (2012) DNA methylation arrays as surrogate measures of cell mixture distribution. BMC bioinformatics 13:86. doi:10.1186/1471-2105-13-86
Houseman EA, Molitor J, Marsit CJ (2014) Reference-free cell mixture adjustments in analysis of DNA methylation data. Bioinformatics 30:1431–1439. doi:10.1093/bioinformatics/btu029
Jazwinski SM et al (2010) HRAS1 and LASS1 with APOE are associated with human longevity and healthy aging. Aging Cell 9:698–708. doi:10.1111/j.1474-9726.2010.00600.x
Karasik D, Demissie S, Cupples LA, Kiel DP (2005) Disentangling the genetic determinants of human aging: biological age as an alternative to the use of survival measures. J Gerontol A Biol Sci Med Sci 60:574–587
Kim S, Jazwinski SM (2015) Quantitative measures of healthy aging and biological age. Healthy Aging Res 4:26. doi:10.12715/har.2015.4.26
Kim S, Myers L, Ravussin E, Cherry KE, Jazwinski SM (2016a) Single nucleotide polymorphisms linked to mitochondrial uncoupling protein genes UCP2 and UCP3 affect mitochondrial metabolism and healthy aging in female nonagenarians. Biogerontology 17:725–736. doi:10.1007/s10522-016-9643-y
Kim S, Simon E, Myers L, Hamm LL, Jazwinski SM (2016b) Programmed cell death genes are linked to elevated creatine kinase levels in unhealthy male nonagenarians. Gerontology 62:519–529. doi:10.1159/000443793
Kim S, Welsh DA, Cherry KE, Myers L, Jazwinski SM (2013) Association of healthy aging with parental longevity. Age 35:1975–1982. doi:10.1007/s11357-012-9472-0
Kim S, Welsh DA, Myers L, Cherry KE, Wyckoff J, Jazwinski SM (2015) Non-coding genomic regions possessing enhancer and silencer potential are associated with healthy aging and exceptional survival. Oncotarget 6:3600–3612. doi:10.18632/oncotarget.2877
Kim S, Welsh DA, Ravussin E, Welsch MA, Cherry KE, Myers L, Jazwinski SM (2014) An elevation of resting metabolic rate with declining health in nonagenarians may be associated with decreased muscle mass and function in women and men, respectively. J Gerontol A Biol Sci Med Sci 69:650–656. doi:10.1093/gerona/glt150
Koch CM, Wagner W (2011) Epigenetic-aging-signature to determine age in different tissues. Aging 3:1018–1027. doi:10.18632/aging.100395
Kulminski A, Ukraintseva SV, Akushevich I, Arbeev KG, Land K, Yashin AI (2007a) Accelerated accumulation of health deficits as a characteristic of aging. Exp Gerontol 42:963–970. doi:10.1016/j.exger.2007.05.009
Kulminski AM, Ukraintseva SV, Akushevich IV, Arbeev KG, Yashin AI (2007b) Cumulative index of health deficiencies as a characteristic of long life. J Am Geriatr Soc 55:935–940. doi:10.1111/j.1532-5415.2007.01155.x
Lin Q, Weidner CI, Costa IG, Marioni RE, Ferreira MR, Deary IJ, Wagner W (2016) DNA methylation levels at individual age-associated CpG sites can be indicative for life expectancy. Aging 8:394–401. doi:10.18632/aging.100908
Marioni RE et al (2015) DNA methylation age of blood predicts all-cause mortality in later life. Genome Biol 16:25. doi:10.1186/s13059-015-0584-6
Matteini AM et al (2010) Heritability estimates of endophenotypes of long and health life: the Long Life Family Study. J Gerontol A Biol Sci Med Sci 65:1375–1379. doi:10.1093/gerona/glq154
Mitnitski A, Bao L, Rockwood K (2006) Going from bad to worse: a stochastic model of transitions in deficit accumulation, in relation to mortality. Mech Ageing Dev 127:490–493. doi:10.1016/j.mad.2006.01.007
Mitnitski AB, Graham JE, Mogilner AJ, Rockwood K (2002a) Frailty, fitness and late-life mortality in relation to chronological and biological age. BMC Geriatr 2:1
Mitnitski AB, Mogilner AJ, MacKnight C, Rockwood K (2002b) The mortality rate as a function of accumulated deficits in a frailty index. Mech Ageing Dev 123:1457–1460
Mitnitski AB, Mogilner AJ, Rockwood K (2001) Accumulation of deficits as a proxy measure of aging. ScientificWorldJournal 1:323–336. doi:10.1100/tsw.2001.58
Perna L, Zhang Y, Mons U, Holleczek B, Saum KU, Brenner H (2016) Epigenetic age acceleration predicts cancer, cardiovascular, and all-cause mortality in a German case cohort. Clin Epigenetics 8:64. doi:10.1186/s13148-016-0228-z
R_Core_Team (2016) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
Rakyan VK et al (2010) Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains. Genome Res 20:434–439. doi:10.1101/gr.103101.109
Reinius LE et al (2012) Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS One 7:e41361. doi:10.1371/journal.pone.0041361
Rockwood K, Andrew M, Mitnitski A (2007) A comparison of two approaches to measuring frailty in elderly people. J Gerontol A Biol Sci Med Sci 62:738–743
Rockwood K, Fox RA, Stolee P, Robertson D, Beattie BL (1994) Frailty in elderly people: an evolving concept. CMAJ 150:489–495
Rockwood K, Mitnitski A (2007) Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci 62:722–727
Rockwood K, Stadnyk K, MacKnight C, McDowell I, Hebert R, Hogan DB (1999) A brief clinical instrument to classify frailty in elderly people. Lancet 353:205–206. doi:10.1016/S0140-6736(98)04402-X
Searle SD, Mitnitski A, Gahbauer EA, Gill TM, Rockwood K (2008) A standard procedure for creating a frailty index. BMC Geriatr 8:24. doi:10.1186/1471-2318-8-24